Burning Rock Biotech (BNR) Free Cash Flow: 2020-2024
Historic Free Cash Flow for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$13.4 million.
- Burning Rock Biotech's Free Cash Flow rose 114.52% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.8 million, marking a year-over-year increase of 73.37%. This contributed to the annual value of -$13.4 million for FY2024, which is 63.99% up from last year.
- According to the latest figures from FY2024, Burning Rock Biotech's Free Cash Flow is -$13.4 million, which was up 63.99% from -$37.2 million recorded in FY2023.
- Over the past 5 years, Burning Rock Biotech's Free Cash Flow peaked at -$13.4 million during FY2024, and registered a low of -$107.1 million during FY2021.
- Its 3-year average for Free Cash Flow is -$41.9 million, with a median of -$37.2 million in 2023.
- Per our database at Business Quant, Burning Rock Biotech's Free Cash Flow crashed by 421.99% in 2021 and then skyrocketed by 63.99% in 2024.
- MRY analysis of 5 years shows Burning Rock Biotech's Free Cash Flow stood at -$20.5 million in 2020, then plummeted by 421.99% to -$107.1 million in 2021, then grew by 29.73% to -$75.2 million in 2022, then soared by 50.59% to -$37.2 million in 2023, then skyrocketed by 63.99% to -$13.4 million in 2024.
- Its Free Cash Flow was -$13.4 million in FY2024, compared to -$37.2 million in FY2023 and -$75.2 million in FY2022.